MMP9 and neoplasm: Tumor-derived EVs deliver ECM-MMPs inducers which can contribute to matrix degradation in different diseases103,104: For instance, EVs derived from ovarian cancer contain high levels of MMP-2, MMP-9, and urokinase-type plasminogen activator proteinases that could degrade the ECM104.